12:00 AM
 | 
Mar 06, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rescula unoprostone isopropyl regulatory update

Ciba, the eye care subsidiary of Novartis AG (SWX:NOVN), completed marketing submissions in...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >